Middle East and Africa Brain Cancer Diagnostics Market Segments and Growth by 2028

Middle East and Africa Brain Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Diagnostic Type (Imaging Test, Lumbar Puncture, Biopsy, Molecular Testing, and Others); Cancer Type (Acoustic Neuroma, Astrocytoma, Craniopharyngiomas, Ganglioneuromas, Glioblastoma Multiforme, Meningiomas, Ependymomas, and Others); End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others)

Historic Data: 2019-2020 | Base Year: 2021 | Forecast Period: 2022-2028
  • Status : Published
  • Report Code : TIPRE00025900
  • Category : Life Sciences
  • No. of Pages : 152
  • Available Report Formats : pdf-format excel-format
  • Last update date : November 16, 2021
Middle East and Africa Brain Cancer Diagnostics Market Segments and Growth by 2028
Report Date: November 16, 2021   |   Report Code: TIPRE00025900 Email: sales@theinsightpartners.com

2021 Market Size

US$ 87.4 Mn

Base year value

2028 Forecast

US$ 237.0 Mn

Projected by 2028

CAGR 2022-2028

15.3 %

Growth rate

Addressable Market

US$ 1,125.60 Mn

(2022-2028)

The brain cancer diagnostics market in Middle East and Africa is expected to grow from US$ 87.4 million in 2021 to US$ 237.0 million by 2028; it is estimated to grow at a CAGR of 15.3% from 2021 to 2028.

Artificial intelligence involves the use of powerful computers to perform tasks usually associated with human intelligence. A type of artificial intelligence called deep learning uses complex mathematical algorithms (sometimes called convolutional neural networks) to extract features from data and then "train" them. This training enables the algorithm to recognize patterns and perform tasks such as analysing images. To combine the powerful functions of the SRH imager with AI, the researchers began to perform algorithm training on the brain tumor tissue images produced by the SRH. The researchers pointed out that the ability of artificial intelligence technology and pathologists to verify each other highlights the need for pathologists to cooperate with artificial intelligence technology to interpret challenging cases and ensure the highest possible diagnostic accuracy. Both SRH and AI imaging are emerging technologies, so integrating them into healthcare will be challenging. AI technology enables surgeons to identify areas containing tumors or healthy tissue speedily and precisely. Thus, SRH‒artificial intelligence is being increasingly used to enhance brain tumor diagnosis during surgery. 

The pandemic has caused disruptions to health services worldwide and has impacted the ability of countries to address and respond to critical conditions like brain cancer. In many countries, diagnostics services have been disrupted, and supply chains for key commodities have been stretched. In Africa, COVID-19 has threatened the control of major health conditions including brain cancer. As COVID-19 continues to spread in Africa, there are concerns over its impact on market, limited diagnosis, and decreased access to expert neurosurgeons further impacting the market in the region. However, as the pandemic situation overcomes, the demand for several diagnostics modalities used in brain cancer diagnosis will increase.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the brain cancer diagnostics market. The Middle East and Africa brain cancer diagnostics market is expected to grow at a good CAGR during the forecast period.

Middle East and Africa Brain Cancer Diagnostics Market Segmentation          

By Diagnostic Type

  • Imaging Test
    • MRI
    • CT Scan
    • PET
  • Biopsy
  • Molecular Testing
  • Lumbar Puncture
  • Others

By Cancer Type

  • Glioblastoma Multiforme
  • Astrocytomas
  • Ependymomas
  • Others

By End User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others

By Country

  • Middle East and Africa
    • UAE
    • Saudi Arabia
    • South Africa
    • Rest of Middle East and Africa

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers A
  • GE Healthcare
  • Biocept, Inc.
  • Koninklijke Philips N.V
  • Canon Medical Systems
  • Hitachi, Ltd.
  • Neusoft Medical Systems

Middle East and Africa Brain Cancer Diagnostics Report Scope

Report Attribute Details
Market size in 2021 US$ 87.4 Million
Market Size by 2028 US$ 237.0 Million
CAGR (2021 - 2028) 15.3%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Diagnostic Type
  • Imaging Test
  • Lumbar Puncture
  • Biopsy
  • Molecular Testing
By Cancer Type
  • Acoustic Neuroma
  • Astrocytoma
  • Craniopharyngiomas
  • Ganglioneuromas
  • Glioblastoma Multiforme
  • Meningiomas
  • Ependymomas
By End User
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
Regions and Countries Covered Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers A
  • GE Healthcare
  • Biocept, Inc.
  • Koninklijke Philips N.V
  • Canon Medical Systems
  • Hitachi, Ltd.
  • Neusoft Medical Systems
Trupti Wadekar
Assistant Manager,
Market Research & Consulting

Trupti is a senior consultant with over 10 years of experience in the Healthcare sector, specializing in pharmaceuticals, biotechnology, and life-sciences markets. She holds a Bachelor’s degree in Biotechnology and an MBA with dual specialization in Marketing and Pharmaceuticals & Biotechnology, combining a strong scientific foundation with a strategic and commercial perspective. Her professional experience encompasses market research, competitive intelligence, strategic advisory, and business development, supporting clients across diverse and evolving healthcare markets.

She has worked extensively on market sizing and assessment, growth strategy, market expansion, and strategic decision-making initiatives, helping clients identify opportunities and address complex business challenges. Trupti brings strong expertise in client engagement, stakeholder management, team leadership, and translating research findings into actionable business insights. Her ability to connect scientific understanding with market dynamics and commercial strategy enables her to deliver practical, high-impact solutions aligned with client objectives.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA